Navigation Links
Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
Date:2/13/2009

EVENUE $14,795,746 $24,954,288 $32,919,474 $44,327,357 COST OF SALES 12,801,591 19,086,274 27,732,778 33,865,306 GROSS PROFIT 1,994,155 5,868,014 5,186,696 10,462,051 SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 2,322,885 1,814,376 4,752,675 3,510,931 INCOME (LOSS) FROM OPERATIONS (328,730) 4,053,638 434,021 6,951,120 OTHER INCOME (EXPENSE): Earnings on equity investment 31,561 977 33,412 149,756 Other income 43,312 69,962 55,181 109,709 Other expense (242,202) (26,495) (251,112) (203,844) Interest expense and other charges (41,667) (519,417) (63,506) (935,881) Interest income 79,380 32,243 96,673 98,404 Other income (expense), net (129,616) (442,730) (129,352) (781,856) INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES (458,346) 3,610,908 304,669 6,169,264 PROVISION FOR INCOME TAXES 15,541 481,323 148,760 787,168 NET INCOME (LOSS) (473,887) 3,129,585 155,909 5,382,096 OTHER COMPREHENSIVE INCOME: Foreign currency translation adjustments 123,453 140,556 287,726 1,412,651 COMPREHENSIVE INCOME (LOSS) $(350,434) $3,270,141 $443,635 $6,794,747 EARNINGS (LOSS) PER SHARE Basic $(0.02) $0.17 $0.01 $0.28 Diluted $(0.02) $0.15 $0.01 $0.27 WEIGHTED AVERAGE NUMBER OF SHARES Basic 19,123,338 18,961,992 19,109,149 18,918,496 Diluted 19,123,338 20,296,006
'/>"/>
SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
2. Shengtai Pharmaceutical, Inc. Appoints New CFO
3. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
4. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
5. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
6. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
9. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
10. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... and technology platform company serving the global pharmaceutical, ... an Investigational New Drug (IND) application for WuXi ... has been accepted for review by the China ... In September 2012, MedImmune, the global biologics research ...
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... dealing with certain matters, including the appointment of auditors, ... March 26, 2015 (the "Meeting") was adjourned, as previously ... at 11:00 a.m. ( Toronto time). ... from that previous disclosed. The Meeting will reconvene at ...
(Date:3/26/2015)... PAREXEL International Corporation (Nasdaq: ... organization , announced today that the Company ... all of the business assets of privately-owned Quantum ... specialized pharmacovigilance services, based in Chandigarh, India.  ... monitoring, and prevention of adverse effects with ...
(Date:3/25/2015)... is one of the most attractive in the emerging ... a growing economy and increasing government investment in healthcare, ... Russian market is set to grow at twice the ... around 10-15% annually reaching an approximate market value of ... Green Cross provides total healthcare solutions that ...
Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3SQI Diagnostics Inc. Announces Adjournment of Meeting 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4
... Tandem Labs, a leading contract,research organization ... services to the pharmaceutical,industry, announced that it ... 4000(TM) LC/MS/MS systems for its New England ... facility,s current triple,quadrupole LC/MS/MS capacity, allowing it ...
... Identify Pathways and ... Metabolomic Data, REDWOOD CITY, Calif., Oct. 9 ... to help life science researchers,generate insights from biological ... within Ingenuity,Pathways Analysis to help researchers understand metabolomics ...
... SAN DIEGO, Oct. 8 SGX Pharmaceuticals, Inc.,(Nasdaq: ... on October 11,2007, at 1:00 p.m. Pacific Daylight Time. ... will provide an overview of the,Company,s oncology pipeline. The ... the Palace Hotel in San Francisco. A live ...
Cached Biology Technology:Tandem Labs' New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England 2Ingenuity Systems Launches New Metabolomics Solution Within IPA 2
(Date:3/23/2015)... Conn. , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... new advertising campaign on CNBC television starting March 30 th ... will commence airing in New York ... Officer said: "We are excited about our new ad campaign ...
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
(Date:3/16/2015)... , March 16, 2015 ... Systems GmbH will present groundbreaking innovations in biometric ... Hanover, Germany .      (Photo: ... latest biometric innovation is well at the forefront: ... generation e-gate made in Germany ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3
... from space for the first time using optical radiance ... Envisat. The ability to monitor Sargassum globally will allow ... ocean and better predict climate change. Credit: ESA ... in its dense floating vegetation, has been detected from ...
... E. Fox, NIH/NRSA postdoctoral fellow at the University of Oregon, ... legumes to recruit soil bacteria needed to provide a natural ... applying pesticides to boost crop yields may instead be contributing ... , According to years of research both in the test ...
... ovarian tissue, blood vessels, even whole organs available when ... directly comparing slow-freezing techniques, used successfully for decades to ... of cryopreservation that transforms tissues into durable glass-like structures. ... Medical College of Georgia are comparing the two approaches ...
Cached Biology News:Envisat captures first image of Sargassum from space 2Pesticides choke pathway for nature to produce nitrogen for crops 2Pesticides choke pathway for nature to produce nitrogen for crops 3Studies to find better ways to preserve human eggs, ovarian tissue under way 2Studies to find better ways to preserve human eggs, ovarian tissue under way 3Studies to find better ways to preserve human eggs, ovarian tissue under way 4Studies to find better ways to preserve human eggs, ovarian tissue under way 5
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Chicken polyclonal to DCTD ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez GeneID: 1635 Swiss Protein ID: P32321...
...
Biology Products: